Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04144933Phase 3Recruiting
Phase 3, randomised, triple-blind trial of lidocaine, ketamine, dexmedetomidine and magnesium sulfate in postoperative ileus (POI), sponsored by University of Saskatchewan. Started May 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04144933.